Literature DB >> 16362366

The effect of circulating nitric oxide level on axial bone mineral density in postmenopausal Turkish women with rheumatoid arthritis: A preliminary report.

Gunsah Sahin1, Hayal Guler, Melek Sezgin, Nurgul Arinci Incel, Gurbuz Polat.   

Abstract

The aim is to investigate the differences in the circulating nitric oxide (NO) levels of rheumatoid arthritis (RA) patients, healthy controls and osteoporotic (OP) patients. We also examined whether the circulating NO levels may be correlated with bone mineral density (BMD) in RA patients. Forty-five patients with RA, 30 healthy women and 30 osteoporotic patients were recruited from the outpatient clinic. All the subjects were female and postmenopausal. Serum NO levels were measured (Nitrite/Nitrate, calorimetric method 1746081, Roche diagnostics, Mannheim, Germany) and BMD was measured at the spine and hip using dual energy X-Ray absorbtiometry (DEXA, Norland XR-46). Height and weight were measured and body mass index was calculated. Circulating NO levels were significantly higher in RA patients than other groups. Moreover, the RA group showed significantly higher BMD at lumbar spine and femoral neck regions compared to osteoporotic patients. However, the RA group showed significantly lower BMD at all sites than the controls. There was no correlation between circulating NO levels and BMD in all groups. We suggest that, unlike postmenopausal osteoporosis, inflammation induced osteoporosis is associated with RA is characterised by relatively preserved bone mass at the axial bone regions, and circulating NO levels as a parameter or determinant of inflammation are not correlated with axial BMD in RA patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362366     DOI: 10.1007/s00296-005-0091-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

Review 1.  Nitric oxide in rheumatology.

Authors:  C Bernardeau; E Dernis-Labous; H Blanchard; D Lamarque; M Breban
Journal:  Joint Bone Spine       Date:  2001-12       Impact factor: 4.929

2.  Elevated levels of nitrate in rheumatoid arthritis.

Authors:  O Onur; A S Akinci; F Akbiyik; I Unsal
Journal:  Rheumatol Int       Date:  2001-05       Impact factor: 2.631

3.  Estimation of dietary intake of nitrate and nitrite in Great Britain.

Authors:  T M Knight; D Forman; S A Al-Dabbagh; R Doll
Journal:  Food Chem Toxicol       Date:  1987-04       Impact factor: 6.023

Review 4.  Nitric oxide.

Authors:  A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

5.  Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years.

Authors:  Glenn Haugeberg; Ragnhild E Ørstavik; Till Uhlig; Jan A Falch; Johan I Halse; Tore K Kvien
Journal:  Arthritis Rheum       Date:  2002-07

6.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.

Authors:  H Sakurai; H Kohsaka; M F Liu; H Higashiyama; Y Hirata; K Kanno; I Saito; N Miyasaka
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins.

Authors:  S H Ralston; P S Grabowski
Journal:  Bone       Date:  1996-07       Impact factor: 4.398

8.  Assessment of dietary nitrate intake by a self-administered questionnaire and by overnight urinary measurement.

Authors:  P A Van den Brandt; W C Willett; S R Tannenbaum
Journal:  Int J Epidemiol       Date:  1989-12       Impact factor: 7.196

9.  Nitric oxide: an important articular free radical.

Authors:  G A Murrell; M M Doland; D Jang; C Szabo; R F Warren; J A Hannafin
Journal:  J Bone Joint Surg Am       Date:  1996-02       Impact factor: 5.284

10.  Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase.

Authors:  S H Ralston; D Todd; M Helfrich; N Benjamin; P S Grabowski
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

View more
  2 in total

Review 1.  Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis.

Authors:  Fulong Zhao; Lijuan Guo; Xuefei Wang; Yakui Zhang
Journal:  Arch Osteoporos       Date:  2021-01-05       Impact factor: 2.617

2.  SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production.

Authors:  Lei Zhang; Rui-Jie Dang; Hong Li; Ping Li; Yan-Mei Yang; Xi-Min Guo; Xiao-Yan Wang; Nan-Zhu Fang; Ning Mao; Ning Wen; Xiao-Xia Jiang
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.